Lv42
590 积分 2022-03-02 加入
Binding sites and design strategies for small molecule GLP-1R agonists
3天前
已完结
"Next-in-class" GLP-1R Danuglipron- and Lotiglipron-like Agonists: A Patent Review (2020-2024)
3天前
已完结
新型植物甾醇法合成氢化可的松关键中间体的研究
13天前
已完结
Revisiting the role of steroidal therapeutics in the 21st century: an update on FDA approved steroidal drugs (2000–2024)
13天前
已完结
Chemical modification of hyaluronic acid as a strategy for the development of advanced drug delivery systems
15天前
已完结
Development of a Manufacturing Process for a Key (S)-5-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1H-indole Intermediate for Orforglipron. Part III. Development of a Telescoped Phase-Transfer-Catalyzed Alkylation and Cyclopropanation Process
1个月前
已完结
Development of a Manufacturing Process for a Key (S)-5-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1H-indole Intermediate for Orforglipron. Part I. Selection of an Evans Auxiliary-Assisted Asymmetric 1,4-Addition Route
1个月前
已完结
ChemTransGNN + +: from Reactants to Products via Multiscale Graph-Transformer Modeling of Reaction Pathways
1个月前
已完结
Status check: biocatalysis; its use with and without chemocatalysis. How does the fine chemicals industry view this area?
1个月前
已完结
Generation of New-to-Nature Natural Products through Synthesis and Biosynthesis
1个月前
已完结
皖公网安备34019202002308
